These results collectively indicate that the therapeutic effects of JWQZG on NAFLD may be mediated through a multitarget and multi-pathway mechanism, involving processes such as lipid metabolism, insulin signaling, and inflammation. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.